Balchem Corp (BCPC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 704 | 799 | 942 | 922 | 954 | 1,037 | 1,086 | 1,132 |
| Operating profit | $m | 218 | 229 | ||||||
| Net profit | $m | 85 | 96 | 105 | 109 | 128 | 155 | 164 | 176 |
| EPS reported | $ | 4.75 | 5.08 | ||||||
| Operating cashflow per share | $ | 6.64 | 6.81 | ||||||
| Capex per share | $ | 1.33 | 1.50 | ||||||
| FCF per share | $ | 5.31 | 5.31 | ||||||
| Free cash flow | $m | 173 | 171 | ||||||
| Net debt | $m | 105 | 66 | ||||||
| Book value equity | $m | 1,257 | 1,302 | ||||||
| Book value per share | $ | 38.57 | 40.39 | ||||||
| Number of shares | m | 32.6 | 32.24 | ||||||
| DPS (TTM paid) | $ | 0.96 | 0.96 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 32.29 | 33.05 | ||||||
| P/B LTM | x | 3.98 | 3.84 | ||||||
| P/S LTM | x | 4.82 | 4.60 | ||||||
| P/FCF LTM | x | 28.89 | 29.18 | ||||||
| EV/EBITDA LTM | x | 20.11 | 18.35 | ||||||
| EV/Sales LTM | x | 4.93 | 5.17 | ||||||
| Earnings Yield LTM | % | +3.10% | +3.03% | ||||||
| FCF Yield | % | +3.46% | +3.43% | ||||||
| Quality | |||||||||
| ROE | % | +12.31% | +12.79% | ||||||
| ROIC | % | +11.07% | +11.50% | ||||||
| Operating margin | % | +21.05% | +21.13% | ||||||
| Gross margin | % | +35.74% | +36.29% | ||||||
| FCF/Sales | % | +16.69% | +15.78% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +20.87% | +29.26% | ||||||
| Sales Growth YoY | % | +8.75% | +13.86% | ||||||
| Net Income Growth YoY | % | +20.53% | +27.97% | ||||||
| FCF Growth | % | +18.27% | +17.10% | ||||||
| Operating Profit Growth | % | +19.37% | +25.47% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.57% | +0.56% | ||||||
| Dividend Growth | % | +10.34% | +10.34% | ||||||
| Payout Ratio | % | +18.27% | +18.72% | ||||||
| FCF/Debt | x | 0.90 | 1.03 | ||||||
| Net Debt/EBITDA | x | 0.46 | 0.37 | ||||||
| EBIT/Net interest | x | 21.37 | 25.29 | ||||||
| Net debt/market cap | % | +3.58% | +2.82% | ||||||
| Net debt/Equity | x | 0.08 | 0.05 | ||||||
| Gross debt/equity | x | 0.15 | 0.13 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free